Your session is about to expire
← Back to Search
Dry Needling for Provoked Vestibulodynia
Study Summary
This trial studies the effects of dry needling to treat pelvic pain in women with provoked vestibulodynia. Participants randomized to receive real or sham needle therapy over 6 weeks, with outcomes measured.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have gone through menopause.I haven't changed my pain or mood medication in the last 3 months.I have previously received dry needling or acupuncture treatments.I experience significant pain during sex, rating it 5 or more out of 10.I have severe pelvic organ prolapse or had a urinary/vaginal infection recently.I have had surgery on my vulva, vagina, or pelvis before.I have been diagnosed with provoked vestibulodynia by a gynecologist.I have vulvo-vaginal pain not caused by sex, skin conditions, herpes, or thinning tissues.
- Group 1: Experimental: Real Dry needling
- Group 2: Sham: Non penetrating dry needling
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this test restricted to individuals below a certain age threshold?
"According to this research project's requirements, the minimum age of participation is 18 and the maximum age ceiling is 45."
Am I qualified to join this research project?
"In order to meet the requirements of this clinical trial, patients need to have a history of provoked vestibulodynia and fall between 18-45 years old. Currently, researchers are seeking 46 volunteers for participation."
Are there still opportunities to partake in this clinical experiment?
"Affirmative, according to the records published on clinicaltrials.gov this trial is still recruiting patients. It was initially announced on March 30th 2023 and modified for the last time on March 21st of that same year. There are 46 participants needed from 1 medical centre."
What is the uppermost limit of participants in this trial?
"Affirmative. According to the information made available on clinicaltrials.gov, this trial is still open for enrollment and was first published on March 30th 2023 with its last edit being made 21 days later. At present, 46 participants are needed from just one medical site."
What is the main goal of this clinical experiment?
"The primary aim of this 6-week trial is to determine the retention rate. Secondary objectives involve gauging changes in central sensitization (Central Sensitisation Inventory, 0 - 100), pain quality (McGill-Melzack Questionnaire, 0 - 78) and catastrophizing levels (Pain Catastrophising Scale, 0 - 52)."
Share this study with friends
Copy Link
Messenger